04-25-2024, 04:08 PM
Definitely! Another medication gaining attention is Sacituzumab Govitecan. It's an antibody-drug conjugate approved for metastatic triple-negative breast cancer. Early studies get shown promising results in patients who get previously undergone multiple treatments.